# Double Blind Study to Evaluate the Efficacy of Collagenase Histolyticum in the Treatment of Lipoma

> **NCT02249052** · PHASE2 · COMPLETED · sponsor: **Gerut, Zachary, M.D.** · enrollment: 19 (actual)

## Conditions studied

- Lipoma

## Interventions

- **DRUG:** AA4500
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02249052
- **Lead sponsor:** Gerut, Zachary, M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2016-04
- **Final completion:** 2016-06
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2017-02-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02249052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02249052, "Double Blind Study to Evaluate the Efficacy of Collagenase Histolyticum in the Treatment of Lipoma". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02249052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*